REDWOOD CITY, Calif., Feb. 28, 2020 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the settlement of its patent infringement lawsuit against Stimwave Technologies, Inc.  Stimwave has agreed to cease commercialization of all high frequency spinal cord stimulation systems worldwide.  The lawsuit …